等待开盘 12-19 09:30:00 美东时间
+0.980
+1.48%
Novo's trial setback tests GLP-1-heavy ETFs, highlighting concentration risks while Eli Lilly's diversified pipeline offers relative resilience.
11-25 01:06
Belpointe PREP (AMEX:OZ) reported quarterly losses of $(3.21) per share. This is a 68.95 percent decrease over losses of $(1.90) per share from the same period last year. The company reported $2.382 million in sales
11-15 05:56
Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced
10-21 20:04
10月17日,第十届世界传统武术锦标赛首个比赛日在四川乐山峨眉山市拉开序幕。赛场内高手云集,参赛选手各展武艺,观众的呐喊加油声此起彼伏。赛事分境内与境外两大组别...
10-17 21:22
Belpointe OZ has completed a $204.14 million refinancing transaction for its Sarasota development, Aster & Links, reducing existing debt and supporting the project's lease-up and stabilization. The refinance will save the company millions annually. Aster & Links, a 424-unit luxury multifamily property with over 50,000 sq. ft. of retail, has strong leasing demand and is anchored by Sprouts Farmers Market. Located in downtown Sarasota, it offers hi...
10-09 20:01
Juki Corporation ( ($JP:6440) ) has shared an announcement. JUKI Corporation an...
10-09 14:27
Belpointe OZ’s VIV, a 269-unit mixed-use development in St. Petersburg, FL, has begun leasing with all units receiving Temporary Certificates of Occupancy. Managed by Bozzuto Group, VIV is set to welcome residents starting in November 2025. Located in downtown St. Petersburg, VIV offers modern residences, premium amenities, and ground-floor retail, with convenient access to dining, cultural attractions, and waterfront parks. Belpointe OZ, a publi...
10-06 20:01
An update from Belpointe PREP ( ($OZ) ) is now available. On September 29, 2025...
10-04 05:51
1,508% increase in revenues from IPP production supporting the Company's strategy of generating long-term recurring revenues 253% increase in assets fueled by growth of IPP portfolio This ne...
10-02 19:00
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that it has agreed on a collaborative framework with the U.S. Food and Drug Administration (FDA) for the resolution of certain disputes regarding
10-02 05:08